Norman Levine, M.D.
Norman Levine, M.D., is a private practitioner in Tucson, Ariz. He also is a member of the Dermatology Times Editorial Advisory board and a co-medical editor.
AAD insights and takeaways
In this article, Dr. Norman Levine sums up his takeaways from the American Academy of Dermatology annual meeting, beginning with a presentation by two physicians who addressed the difficulties of managing hidradenitis suppurativa, such as fixed dosing. He also addressed controversies associated with treatments for atopic dermatitis. Apparently, bleach baths are no better than regular baths in improving skin symptoms.
Venture capital and the future of dermatology: A reassessment
Dr. Norman Levine offers bits of advice for those considering this type of change in your practice for those considering selling their practices to venture capital-backed enterprises based on his experience with one such company.
A different perspective on venture capital and the future of dermatology
If we do not evolve ... we will soon be an extinct species of medical practitioner, Dermatology Times Editorial Advisor says in his column this month. He shares his experience and considerations with negotiating the sale of his practice to a venture capital backed firm.
Maximizing the physician-patient relationship
Norman Levine, M.D., notes that being a physician is not easy. A large part of the difficulty centers on the patient-doctor relationship and how one maximizes the benefits that the patient accrues by the care he receives.
If I ruled the (dermatology) world
Dr. Norman Levine muses on an alternate universe in which he makes the rules for anything related to the dermatology specialty. After reading, he notes many may be relieved that he will never rule the (dermatology) world. But are changes necessary? You tell us.
Contrary to public belief
A seasoned dermatologist shares his views about dermatologists being overpaid, when to treat and when not to treat, and how best to stay informed.
Can we cut back on lab testing?
We utilize numerous medications in dermatology where potentially severe side effects can occur and can be detected by laboratory analysis. However, many commonly prescribed drugs rarely cause problems but have acquired the reputation of potentially toxic agents, which require close laboratory monitoring. Although many would disagree me, these are the medications that dermatologists over test.
Dermatologists are wound care specialists
When routine skin injuries such as mild burns, skin tears, uncomplicated stasis ulcers and minor post-operative wound complications become a routine part of the wound care center purview and are no longer considered a part of what dermatologists can do or wish to do, the dermatology discipline shrinks further toward a marginalized specialty. Learn more
The tale of the $220 tube of clobetasol cream
The economic realities of increased prices for medications strikes at the heart of the services that dermatologists provide for patients.
Sunscreen safety and efficacy
Sunscreen safety and efficacy
Sunscreens have become a staple tool in our fight against skin cancer. In spite of the great progress made in educating the public about the value of sunscreens, there remain many doubters about the safety and efficacy of these chemicals. Darrell Rigel, M.D., clinical professor of dermatology at New York University, will help to set the record straight on these agents.